ThursdayJul 11, 2024 10:00 am

Studies Find Tripping, Microdosing Psilocybin Mushrooms Is Growing

Recently released reports suggest that hallucinogenic mushrooms may be the most popular psychedelic drug of choice for the public. The reports also determined that most individuals preferred microdosing over a full trip, with one study observing a 1,250% increase in internet search history on microdosing. The study, which also found that psilocybin searches began outpacing LSD in 2019, was conducted by epidemiologist Eric Leas. The study also determined that the increase in curiosity on microdosing correlated with changes in policies related to both psychedelics and marijuana. In his study, Leas observed that the more liberal a state became related to…

Continue Reading

TuesdayJul 09, 2024 10:00 am

Study Highlights How Psilocybin Impacts Auditory Cortex, Causing Perception Changes

New research has generated new insights into how psilocybin influences the auditory cortex in mice models. Psilocybin is a natural psychedelic compound that is found in more than 200 species of fungi. The compound is known to induce altered states of consciousness when ingested, including changes in cognition, mood and perception. Various studies have investigated the compound’s effectiveness in treating mental-health disorders, including anxiety and depression. While its therapeutic potential is evident, the exact mechanisms via which this psychedelic alters perception and brain function aren’t well understood. Prior studies have shown that psilocybin alters activity patterns in the brain and…

Continue Reading

TuesdayJul 02, 2024 10:00 am

CU Denver Unveils Psychedelic Research Center

The University of Colorado Denver recently launched the CU Denver Center for Psychedelic Research. This center is focused on improving the quality of life of individuals by conducting research on the potential benefits psychedelics may possess in the treatment of various mental, neurological, emotional and other health conditions as well as their possible use in the management of chronic, debilitating illnesses such as cancer. Professor Jim Grigsby, executive director and the center’s chief science officer, revealed that a national study was going on and the center was also planning a number of other studies. Grigsby, who teaches psychology at CU…

Continue Reading

PsychedelicNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050